MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.35 0.23 (9.79%)	0.07 (2.79%)	0.1 (4.03%)	-0.17 (-6.18%)	0.23 (9.79%)	-0.01 (-0.75%)	0.9 (67.67%)	1.25 (93.98%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: PreMarket

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -28.6667
Diluted P/E:: -28.6667
RSI(14) 1m:: 60.0
VWAP:: 2.57
RVol:: 10.374

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	2.24 +0.12 (+5.66%)	Oct 15 16:19
1m	Price increase 1m	2.24 +0.12 (+5.66%)	Oct 15 16:19
1m	Price increase 1m	2.24 +0.12 (+5.66%)	Oct 15 16:19
1m	Price increase 1m	2.24 +0.12 (+5.66%)	Oct 15 16:19
1m	Price increase 1m	2.24 +0.12 (+5.66%)	Oct 15 16:19